Effect of sindilizumab combined with NP regimen on overall survival of patients with lung cancer
Objective To investigate the effect of sindilizumab combined with NP regimen on the overall survival of patients with lung cancer.Methods A total of 98 patients with lung cancer admitted to our hospital from September 2021 to Juanuary 2023 were selected by random number table method and divided into two groups:the control group(49 cases)received sequential treatment with NP regimen,and the study group(49 cases)received combined treatment with sindellizumab on the basis of the control group.The levels of immune function indexes,tumor markers and overall survival were compared between the two groups.Results After treatment,the levels of CD4+,CD3+and CD4+/CD8+in the study group were higher than those in the control group(P＜0.05).After treatment,the levels of CEA,CYFRA21-1 and CA125 in the study group were lower than those in the control group(P＜0.05).The overall survival rate and overall survival of the study group were higher than those of the control group(P＜0.05).Conclusion Sindilizumab combined with NP regimen can effectively prolong the survival period of patients with lung cancer,improve the survival rate of patients,improve the level of tumor markers and immune indexes,and improve the quality of life of patients.
万方数据
维普
